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Nucleotide binding domainOpening and closing of the cystic ﬁbrosis transmembrane conductance regulator (CFTR) chloride channel are
controlled by ATP binding and hydrolysis by its nucleotide binding domains (NBDs). This is presumed to con-
trol opening of a single “gate” within the permeation pathway, however, the location of such a gate has not
been described. We used patch clamp recording to monitor access of cytosolic cysteine reactive reagents to
cysteines introduced into different transmembrane (TM) regions in a cysteine-less form of CFTR. The rate
of modiﬁcation of Q98C (TM1) and I344C (TM6) by both [2-sulfonatoethyl] methanethiosulfonate (MTSES)
and permeant Au(CN)2
− ions was reduced when ATP concentration was reduced from 1 mM to 10 μM, and
modiﬁcation by MTSES was accelerated when 2 mM pyrophosphate was applied to prevent channel closure.
Modiﬁcation of K95C (TM1) and V345C (TM6) was not affected by these manoeuvres. We also manipulated
gating by introducing the mutations K464A (in NBD1) and E1371Q (in NBD2). The rate of modiﬁcation of
Q98C and I344C by both MTSES and Au(CN)2− was decreased by K464A and increased by E1371Q, whereas
modiﬁcation of K95C and V345C was not affected. These results suggest that access from the cytoplasm to
K95 and V345 is similar in open and closed channels. In contrast, modifying ATP-dependent channel gating
alters access to Q98 and I344, located further into the pore. We propose that ATP-dependent gating of
CFTR is associated with the opening and closing of a gate within the permeation pathway at the level of
these pore-lining amino acids.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Cystic ﬁbrosis is caused by genetic mutations that lead to loss of
function of the cystic ﬁbrosis transmembrane conductance regulator
(CFTR), an epithelial cell Cl− channel [1]. CFTR is a member of a
large group of membrane ATPase proteins, the ATP binding cassette
(ABC) transporter family, the vast majority of which act as active
transporters that directly couple ATP hydrolysis to substrate trans-
port across the cell membrane [2]. CFTR however acts not as an active
transporter but as an ion channel in which ATP binding and hydroly-
sis lead to the opening of a pore that mediates the rapid electrogenic
transport of Cl− and other small anions [3,4].
CFTR and other ABC proteins share a modular architecture consist-
ing of two transmembrane domains (TMDs) of six membrane-
spanning α-helices each, and two cytoplasmic nucleotide bindingy hamster kidney; CFTR, cystic
ethanethiosulfonate; MTSES,
ide binding domain; PKA, pro-
α-helix; TMD, transmembrane
& Biophysics, Dalhousie
a B3H 4R2. Tel.: +1 902 494
rights reserved.domains (NBDs). These two homologous halves are joined by a
unique cytoplasmic regulatory domain (R domain), phosphorylation
of which is an absolute pre-requisite for channel activation. In all
ABC proteins, the NBDs are the site of ATP binding and hydrolysis,
which then leads to conformational changes in the TMDs that allow
substrate transport [2,5,6]. In CFTR, the TMDs can exist in either
“open” or “closed” channel conformations, however, the structural
differences between these two conformations are not known. It has
been suggested that in ABC proteins that act as active transporters,
as with all membrane pumps, multiple “gates” must exist within the
substrate translocation pathway, such that this pathway is never con-
tinuously open and thus preventing passive substrate movement
[3,4]. In contrast, as an ion channel it is supposed that opening and
closing of CFTR reﬂects the activity of a single functional gate, and
that opening and closing of this gate is directly controlled by the
NBDs in channels that have already been activated by PKA-
dependent phosphorylation [4]. This has led to the description of
CFTR as a “broken pump” which ultimately evolved from an active
transporter ancestor due to atrophy or uncoupling of one of its
gates [3,4].
The mechanism by which CFTR gating is controlled by a cyclic
scheme of ATP binding and hydrolysis at the NBDs has been well
studied [7–9]. Brieﬂy, in channels that have been activated by protein
kinase A (PKA)-dependent phosphorylation of the R domain, it is
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Fig. 1. Examples of currents in inside-out membrane patches during voltage ramps. (A) Depolarizing voltage ramp protocol used. This voltage ramp was applied every 6 s from a
holding membrane potential of 0 mV. (B) Raw currents carried by Q98C following patch excision from the cell (inside-out), following channel activation with ATP (1 mM) and PKA,
and at different times after application of MTSES (200 μM) to the cytoplasmic face of the membrane. (C) Raw currents carried by Q98C/E1371Q under these same conditions. Note
that background (leak) currents are small in Q98C prior to addition of ATP and PKA, whereas in Q98C/E1371Q, as with all constructs bearing the E1371Qmutation, large constitutive
currents are observed and are not further increased in amplitude by PKA and ATP (see also Refs. [23,24]).
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the two NBDs, triggering channel opening. Hydrolysis of one of these
ATP molecules may then cause channel closing, followed by the re-
lease of hydrolysis products and at least partial dimer dissociation.
These ATP-driven events at the NBDs are presumed to be transmitted
to the TMDs to control pore opening and closing. Since gating is an
ATP-dependent process, the overall channel open probability—
which presumably reﬂects the probability that the gate in the pore
is in the permissive conformation—is affected by factors which impact
NBD function, such as ATP concentration, nucleotide analogs that pre-
vent channel closure, and mutations of key NBD residues controlling
ATP binding afﬁnity and hydrolysis rate.
While the NBDs are presumed to control a single functional gate in
the pore, the proposed structural rearrangements in the TMDs that
are controlled by the NBDs to open and close the channel have not
been described. Speciﬁcally, while localized changes in pore structure
have been suggested to occur during channel activation and gating
[10–14], the location of the putative single ATP-dependent “gate” is
as yet unknown. Recently we showed that access of cysteine-
reactive methanethiosulfonate (MTS) reagents from the cytoplasm
to parts of the CFTR channel pore was prevented in channels that
had not been activated by PKA, but that access to these same sites
was rapid in activated channels [14–16]. There appears to be a
sharp boundary between residues that could be modiﬁed prior to
channel activation (located close to the cytoplasmic ends of the trans-
membrane (TM) α-helices) and those that required channel activa-
tion for modiﬁcation (located further along the TMs from the
inside), suggesting that a physically distinct “barrier” restricts access
from the cytoplasm to the narrowest region of the CFTR channelFig. 2. Timecourse of modiﬁcation byMTSES. Example timecourses of macroscopic currents (
carried by K95C, Q98C, I344C and V345C as indicated, in inside-out membrane patches. Curr
tude after channel activation. Channels were activated with PKA (20 nM) and either a high c
(B)). In (C), patches were also treated with PPi (2 mM) following activation by PKA and ATP
NBD2 mutation E1371Q. In each panel, MTSES (20 μM for K95C, I344C and V345C, and 200
patch at time zero (as indicated by the hatched bar at the bottom of each panel). The decli
nential function in each case.pore in non-activated channels [14,15]. Furthermore, the proximity
of pore-lining side chains from different TMs around this “barrier”
has been demonstrated by cysteine cross-linking [15]. However, the
relationship of this “barrier” in non-activated channels to the ATP-
dependent channel “gate” that is responsible for the dynamic opening
and closing of phosphorylated, activated channels has not been inves-
tigated. Furthermore, while this barrier restricts access to large MTS
reagents, its ability to prevent movement of small substances such
as Cl− ions is also unknown.
In the present work we have investigated ATP-dependent access
of different cytoplasmic substances to different sites in the channel
pore, in channels that have already been activated by PKA-
dependent phosphorylation. Our work is based on the hypothesis
that, for residues beyond the ATP-dependent gate, the rate of access
should be altered by changes in NBD function, whereas between the
gate and the cytoplasm there should be no inﬂuence of gating on
the rate of access. We have used both pharmacological andmutagenic
manipulation of NBD function to inﬂuence overall channel open prob-
ability and, presumably, the orientation of the channel gate controlled
by the NBDs. Our present results allow us to propose a physical loca-
tion within the pore for the channel's ATP-dependent gate that regu-
lates ﬂow of Cl− and other small ions.
2. Materials and methods
Experiments were carried out on baby hamster kidney (BHK) cells
transiently transfected with different forms of human CFTR, as de-
scribed previously [17]. Both wild type CFTR and a variant in which
all 18 endogenous cysteine residues have been substituted by othermeasured at−50 mV during brief voltage excursions from a holding potential of 0 mV)
ent amplitudes were measured every 6 s following attainment of stable current ampli-
oncentration of ATP (1 mM; in (A) and (C)–(E)) or a low concentration of ATP (10 μM;
. In (D) channels also had the NBD1 mutation K464A, and in (E) channels also had the
μM for Q98C; see Materials and methods) was applied to the cytoplasmic face of the
ne in current amplitude following MTSES application has been ﬁtted by a single expo-
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used in the present study also includes a mutation in NBD1 (V510A)
to increase protein expression in the cell membrane [19]. This cys--200
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Fig. 3. Effect of altered channel gating on MTSES modiﬁcation rate constants. Average
modiﬁcation rate constants for MTSES were calculated from ﬁts to data such as those
shown in Fig. 2. In (A), NBD function has been altered pharmacologically using differ-
ent concentrations of ATP and PPi. In (B), NBD function has been altered by the muta-
tions K464A (NBD1) and E1371Q (NBD2). In (A) asterisks indicate a signiﬁcant
difference from PKA and 1 mM ATP, whereas in (B) asterisks indicate a signiﬁcant dif-
ference from cys-less background (Pb0.05 in each case). Mean of data from 3 patches
in each case.
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DNA sequencing.
Macroscopic CFTR currents were recorded using patch-clamp re-
cording from inside-out membrane patches excised from BHK cells as
described in detail previously [21,22]. Following patch excision and re-
cording of background currents (where appropriate), CFTR channels
were activated by exposure to PKA catalytic subunit (20 nM) plus
MgATP (10 μM–1 mM) in the cytoplasmic solution. In some experi-
ments, CFTR channels bearing the NBD2 mutation E1371Q were used.
This mutation results in constitutive, high levels of activity when
expressed in BHK cells [23,24] (see Fig. 1C). Both intracellular
(bath) and extracellular (pipette) solutions contained 150 mM
NaCl, 2 mM MgCl2, and 10 mM N-tris(hydroxymethyl)methyl-2-
aminoethanesulfonate (pH adjusted to 7.4 using NaOH). Currents
were activated using a high (1 mM) or low (10 μM) concentration
of ATP to yield differing levels of overall channel activity. The con-
centration of ATP required for half-maximal open probability of
CFTR is ~50 μM [25], with activity near maximal at 1 mM ATP. In
some cases, CFTR channel activity was further increased by addition
of 2 mM sodium pyrophosphate (PPi) following activation with
1 mM ATP.
Channels were exposed to intracellular cysteine-reactive re-
agents to modify introduced cysteine side chains. [2-sulfona-
toethyl] methanethiosulfonate (MTSES) was initially prepared as
a high concentration (160 mM) stock solutions in distilled water
and stored frozen in small volume aliquots until the time of use,
when it was diluted in bath solution and used immediately.
Potassium dicyanoaurate (KAu(CN)2) was prepared as a high con-
centration (100 mM) stock in normal bath solution and diluted
immediately prior to use.
Following channel activation, CFTR macroscopic current ampli-
tude was monitored during brief voltage deﬂections to ±50 mV
from a holding potential of 0 mV applied every 6 s (Fig. 1). Once
macroscopic current amplitude had reached a steady level, chan-
nels were exposed to cytoplasmic MTSES or Au(CN)2− to modify in-
troduced cysteine side chains [14,15]. In most cases, 20 μM MTSES
and 200 nM Au(CN)2− were used, however, in channels bearing the
Q98C mutation these concentrations were increased to 200 μM
MTSES and 200 nM Au(CN)2− because of the lower rate of modiﬁ-
cation of a cysteine at this position ([15], and Figs. 3, 6 and 7).
These differences in MTSES modiﬁcation rate reﬂect different loca-
tions of introduced cysteines within the pore [14–16]. The similar
low apparent modiﬁcation rate for Q98C by Au(CN)2− (Figs. 6 and
7) suggests that accessibility of this substance is limited by similar
factors as that of MTSES. To measure the rate of modiﬁcation, the
time-dependent change in macroscopic CFTR current amplitude
following addition of MTSES or Au(CN)2− was ﬁtted by a single ex-
ponential function. Since we are interested in monitoring the rate
of modiﬁcation in different channel states, it is possible that the
time-dependent change in current amplitude is the sum of multi-
ple exponential components, however, in all cases the small cur-
rents obtained appeared well ﬁtted by a single exponential. The
measured time constant of exponential current change, τ, was
used to calculate the apparent second order reaction rate constant,
k, from the equation k=1/([R] τ), where [R] is the concentration
of cysteine reactive reagent (MTSES or Au(CN)2−) applied (see
above). As noted above, if there are multiple exponential compo-
nents then the calculated rate constant will reﬂect the weighted
average of multiple rate constants.
For analysis of the voltage-dependent open channel blocking
effects of Au(CN)2− (Fig. 5), macroscopic current–voltage (I–V)
relationships were constructed using depolarizing voltage ramp
protocols [21,26]. Background (leak) currents recorded before
addition of PKA and ATP have been subtracted digitally, leaving
uncontaminated CFTR currents [26,27]. Block was analyzed exactly
as described previously for wild type CFTR [22]. Blockerconcentration–inhibition relationships (Fig. 5C) were ﬁtted by
the equation:
fractional unblocked current ¼ 1= 1þ Au CNð Þ2−
 
=Kd
 Þ ð1Þ
where Kd is the apparent blocker dissociation constant.
Experiments were carried out at room temperature, 21–24 °C.
Values are presented as mean±S.E.M. Tests of signiﬁcance were car-
ried out using a Student's two-tailed t-test unless stated otherwise.
All chemicals were from Sigma-Aldrich (Oakville, ON, Canada), ex-
cept for PKA (Promega, Madison, WI, USA) and MTSES (Toronto Re-
search Chemicals, North York, ON, Canada).
3. Results
3.1. Accessibility of cytoplasmic MTSES
Recently we have used cytoplasmically applied MTS reagents to
modify cysteine residues introduced into CFTR pore-lining TM1 [15]
and TM6 [14]. In these studies, the rate of channel modiﬁcation by neg-
atively charged MTSES was quantiﬁed by measuring the rate of change
of macroscopic current amplitude in fully activated channels following
MTSES application to the cytoplasmic face of inside-out membrane
patches [14,15]. Examples of macroscopic currents recorded from
Q98C-CFTR under these conditions are shown in Fig. 1B, and examples
of timecourses of MTSES-induced current amplitude change are shown
in Fig. 2. As described previously, at K95C and Q98C (TM1) and at
I344C and V345C (TM6), current amplitude is decreased by treatment
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chains [14,15]. In Fig. 2A–C, CFTR channel currents have been activated
in different ways to yield differing levels of NBD-dependent channel ac-
tivity (see Materials and methods). Inspection of these example time-
courses indicates that, while such manipulations have no effect on the
rate of modiﬁcation in K95C or V345C, the rate of modiﬁcation is altered
in both Q98C and I344C (Fig. 2A–C). Quantiﬁcation of the mean modiﬁ-
cation rate constant (as described in Materials and methods) demon-
strates that decreasing ATP concentration from 1 mM (Fig. 2A) to
10 μM(Fig. 2B) to decrease channel opening rate signiﬁcantly decreases
the rate of modiﬁcation in Q98C and I344C (~2.0-fold decrease in mod-
iﬁcation rate constant; Pb0.01), whereas the rate of modiﬁcation of
K95C and V345C was apparently unaffected (P>0.2) (Fig. 3A). Con-
versely, treatment with PPi (2 mM; Fig. 2C) to inhibit channel closure
and increase open probability signiﬁcantly increases the rate of modiﬁ-
cation in Q98C and I344C (2.5–2.8-fold increase in modiﬁcation rate
constant; Pb0.01) but has no effect on the rate of modiﬁcation of K95C
and V345C (P>0.4) (Fig. 3A). These results suggest that pharmacologi-
cal manipulation of NBD function results in changes in the accessibility
of Q98C and I344C—but not K95C or V345C—to cytoplasmic MTSES.
ATP-dependent CFTR channel gating can also be modiﬁed by point
mutations in the NBDs that alter the rate of ATP hydrolysis. Indeed, pre-
vious studies of pore accessibility changes have taken advantage of NBD
mutations K464A and E1371Q [10,11]. The NBD1 mutation K464A de-
creases channel opening rate and has been described as slightly
decreasing overall open probability at moderate ATP concentrations
[9,28,29], whereas mutagenesis of the key catalytic glutamate residue
E1371 in NBD2 prevents ATP hydrolysis to cause dramatic prolongation
of CFTR channel open times, presumably leading to an increase in open
probability [1,30,31]. To alter channel gating by non-pharmacological
means, we therefore combined the NBD mutations K464A and
E1371Q with each of the four cysteine mutants described above. Chan-
nels were activated using PKA (20 nM) and ATP (1 mM) but not ex-
posed to PPi. Constructs including the E1371Q mutation gave large,
spontaneously active currents in BHK cells (Fig. 1C), as described previ-
ously, and likely have an open probability close to one [23,24].
Examples of macroscopic current modiﬁcation of NBD mutant
channels by cytoplasmic MTSES are shown in Fig. 2D–E, and the re-
sults of these experiments are summarized in Fig. 3B. The K464A mu-
tation signiﬁcantly decreased the rate of MTSES modiﬁcation at Q98C
and I344C (2.5–2.9-fold decrease in modiﬁcation rate constant;
Pb0.005) but had no effect on the rate of modiﬁcation at K95C or
V345C (P>0.5) (Fig. 3B). Conversely, the E1371Q mutation signiﬁ-
cantly increased the rate of MTSES modiﬁcation at Q98C and I344CWild type
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Fig. 4. Inhibition of wild-type CFTR by cytoplasmically applied Au(CN)2−. (A, B) Example tim
sions from a holding potential of 0 mV) for wild type (A) and cys-less (B). Following full curr
mic Au(CN)2− (50 μM). (C) Mean effect of this concentration of Au(CN)2− on macroscopic
difference from wild type (Pb0.0001).(3.0–3.1-fold increase in modiﬁcation rate constant; Pb0.02) but
had no effect on the rate of modiﬁcation at K95C or V345C
(P>0.25) (Fig. 3B). These results therefore suggest that altering
NBD function non-pharmacologically by mutagenesis alters accessi-
bility of Q98C and I344C to cytoplasmic MTSES, whereas accessibility
of K95C and V345C are unaffected by NBD-driven channel gating.3.2. Cytoplasmic Au(CN)2 effects on wild type CFTR reﬂect cysteine
modiﬁcation
MTSES is a large molecule that is not permeant in CFTR. As a result,
changes in access of MTSES may not be relevant to changes in pore
conformation that control the movement of Cl− ions. Small permeant
anions such as Au(CN)2− have been used to modify cysteine residues
introduced into the CFTR pore [14,32,33]. However, intracellular
Au(CN)2− also inhibits wild type CFTR by at least two mechanisms
[22]. Previously our group separated and characterized these two in-
hibitory effects as a “gating effect” (a voltage-independent reduction
in channel open probability) and a “conductance effect” (a voltage-
dependent reduction in the rate of Cl− ﬂow in open channels [22]).
The voltage-independent gating effect of intracellular Au(CN)2−, iso-
lated by recording at a depolarized voltage of +50 mV, is illustrated
in Fig. 4. Interestingly, this inhibitory effect was not observed in
cys-less CFTR (Fig. 4). This suggests that the voltage-independent in-
hibition of CFTR by Au(CN)2− (the gating effect) in fact reﬂects modi-
ﬁcation of endogenous cysteine residues in the CFTR protein. In
support of this idea, inhibition of wild type CFTR by Au(CN)2− was
not reversed by washing Au(CN)2− from the bath but could be re-
versed by the reducing agent dithiothreitol (2 mM) (data not shown).
Because the voltage-independent gating effect of Au(CN)2− on
wild type CFTR is not observed in channels that have been treated
by PPi [22]—consistent with this effect reﬂecting modiﬁcation of
channel gating—the overall inhibitory effects of Au(CN)2− are strongly
PPi-sensitive [22]. In contrast, Au(CN)2− inhibition of cys-less CFTR
appears identical in the absence or presence of PPi (2 mM) (Fig. 5).
At −80 mV, the ﬁtted Kd for Au(CN)2− was 84.2 μM in the absence
of PPi, and 76.9 μM in the presence of PPi (Fig. 5C); the voltage-
dependence of Kd is shown in Fig. 5D. This voltage-dependent block-
ing effect appears identical to the open-channel blocking “conduc-
tance effect” of Au(CN)2− previously described for wild type CFTR
(following PPi treatment) [22], suggesting that this pore-blocking
conductance effect is unaltered in cys-less, and is therefore presum-
ably independent of endogenous cysteine residues in wild type CFTR.ys-less
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Fig. 6. Timecourse of modiﬁcation by Au(CN)2−. Example timecourses of macroscopic currents (measured at −50 mV during brief voltage excursions from a holding potential of
0 mV) in inside-out membrane patches. Current amplitudes were measured every 6 s following attainment of stable current amplitude after channel activation. Channels were ac-
tivated with PKA (20 nM) and either a high concentration of ATP (1 mM; in (A) and (C)–(D)) or a low concentration of ATP (10 μM; (B)). Reporter cysteines (K95C, Q98C, and I344C
as indicated) were examined in isolation (A, B) or combined with the NBD mutations K464A (C) or E1371Q (D). In each panel, Au(CN)2− (200 nM for K95C and I344C, and 2 μM for
Q98C; see Materials and methods) was applied to the cytoplasmic face of the patch at time zero (as indicated by the hatched bar at the bottom of each panel). The decline in current
amplitude following Au(CN)2− application has been ﬁtted by a single exponential function in each case.
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− to introduced cysteines
The above results suggest that cys-less CFTR is an appropriate
background in which to study modiﬁcation of introduced cysteines
by Au(CN)2− applied cytoplasmically at concentrations b10 μM. In
fact, we found that currents carried by K95C, Q98C, and I344C were
potently inhibited by much lower concentrations of Au(CN)2−
(200 nM–2 μM; Fig. 6). Both K95C and I344C were rapidly inhibited
by 200 nM Au(CN)2− (Fig. 6), reﬂecting a high modiﬁcation rate con-
stant (Fig. 7). For Q98C, the modiﬁcation rate constant was lower, and
experiments were carried out using a higher concentration ofAu(CN)2− (2 μM). Interestingly, the modiﬁcation rate constant for
MTSES is also lower for Q98C (Fig. 3), probably reﬂecting its location
more deeply into the pore [15]. In contrast, V345C was not sensitive
to inhibition by low concentrations of Au(CN)2−, although it appeared
to show the same sensitivity as cys-less to the voltage-dependent
blocking effects of higher concentrations of Au(CN)2− described
above (data not shown). We therefore compared the rate of
Au(CN)2− inhibition in K95C, Q98C and I344C at two different ATP
concentrations (10 μM and 1 mM), as well as in channels also bearing
the NBD mutations K464A or E1371Q (Fig. 6). Quantiﬁcation of the
mean modiﬁcation rate constant demonstrated that decreasing ATP
AB
CLOSED OPEN
Fig. 8. Simple cartoon models of ATP-dependent gating of the CFTR pore. Both models
show the proposed transition of the TMDs between closed and open states, resulting in
an increase in accessibility from the cytoplasm to Q98 and I344 located relatively deep-
ly along the axis of the TMs (red) but no change in access to K95 and V345 located
more superﬁcially (green). (A) The conformational change (arrow) results in rearran-
gement of the TMDs (in this case, a physical separation). (B) The conformational
change results in removal of a localized physical barrier.
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Fig. 7. Effect of altered channel gating on Au(CN)2− modiﬁcation rate constants. Aver-
age modiﬁcation rate constants for Au(CN)2− in different channel constructs were cal-
culated from ﬁts to data such as those shown in Fig. 6. Asterisks indicate a signiﬁcant
difference from the same mutant in a cys-less background with 1 mM ATP (Pb0.01).
Mean of data from 3 patches in each case.
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modiﬁcation of Q98C and I344C (1.7–1.8-fold decrease in modiﬁca-
tion rate constant; Pb0.005) but had no effect on the rate of modiﬁca-
tion at K95C (P>0.4) (Fig. 7). In addition, the K464A mutation
signiﬁcantly decreased the rate of Au(CN)2− modiﬁcation of Q98C
and I344C (1.4–1.5-fold decrease in modiﬁcation rate constant with
1 mM ATP; Pb0.005) but had no effect on the rate of modiﬁcation
at K95C (P>0.5) (Fig. 7). Conversely, the E1371Q mutation signiﬁ-
cantly increased the rate of Au(CN)2− modiﬁcation at Q98C and
I344C (2.8–3.5-fold increase in modiﬁcation rate constant; Pb0.01)
but had no effect on the rate of modiﬁcation at K95C (P>0.2)
(Fig. 7). These results therefore suggest that similar factors within
the pore restrict the access of cytoplasmic Au(CN)2− and MTSES in
an NBD-dependent fashion.
4. Discussion
The function of CFTR as an ATP-gated ion channel suggests that
ATP binding and hydrolysis by the NBDs should control the opening
and closing of a single functional gate within the permeation path-
way. While changes in CFTR activity have been proposed to lead to
changes in the conformation of speciﬁc parts of the channel pore
[10–16], the location of a gate controlling channel opening has not
been described. We have used pharmacological and mutagenic ma-
nipulations that speciﬁcally alter ATP-dependent channel gating to
investigate changes in the accessibility of different parts of the pore.
All experiments were carried out using channels that had already
been activated by PKA-dependent phosphorylation, minimizing the
effects of changes in R domain function. For two introduced cysteine
residues—K95C in TM1 and V345C in TM6—the rate of modiﬁcation
by cytoplasmic reagents was independent of ATP-dependent channel
gating (Figs. 3, 6), suggesting that access to these residues is similar
both in open channels and in closed channels. In contrast, nearby res-
idues (Q98C in TM1, I344C in TM6) showed strongly state-dependent
accessibility, both to the large MTSES (Fig. 3) and the small, permeant
Au(CN)2− ion (Fig. 7). The rate of modiﬁcation at these two sites was
signiﬁcantly decreased by lowering ATP concentration (Figs. 3A, 7)
and by the K464A mutation (Figs. 3B, 7), and signiﬁcantly increased
by PPi (Fig. 3A) and the E1371Q mutation (Figs. 3B, 7). Given the
well known effects of these manipulations on channel gating and
overall open probability, it seems reasonable to suggest that the rate
of modiﬁcation at Q98C and I344C is positively associated with open
probability, suggesting that open channels are modiﬁed more easily
than are closed channels. We therefore propose that the ATP-
dependent channel gate that controls the dynamic opening and clos-
ing of the pore is located between K95 and Q98 in TM1, and betweenI344 and V345 in TM6. This location appears equivalent to the “barrier”
previously suggested to restrict access in channels prior to PKA-
dependent phosphorylation [14,15], suggesting that these previous
studies were in fact reporting the effects of increased channel open
probability following PKA-dependent phosphorylation. The fact that
this putative gate can regulate the movement of permeant Au(CN)2−
ions into the pore suggests that this gate should also be able to inﬂu-
ence the movement of Cl− ions.
The very high apparent open probability of E1371Q mutant
channels in BHK cells [23,24] means that constructs bearing this
mutation likely give a good estimate of the rate of modiﬁcation of
open channels. As pointed out above, the lack of apparent state-
dependence of modiﬁcation in K95C and V345C suggests that the
rate of modiﬁcation at these sites is similar in closed channels. How-
ever, our measurements of time constants of changes in macroscop-
ic current amplitude in channels that are opening and closing do not
allow us to estimate the rate of modiﬁcation at Q98C and I344C in
closed channels. Previously we suggested that the rate of modiﬁca-
tion of Q98C [15] and I344C [14] is negligible in inactive channels
prior to PKA-dependent phosphorylation. It is possible that phos-
phorylation leads to partial opening of the putative gate and a par-
tial increase in access, and ATP-dependent gating then results in a
further increase in access through this region. This could allow
slow modiﬁcation of Q98C and I344C in phosphorylated, but closed,
channels. However, a simpler explanation is that the gate prevents
access to Q98 and I344 when the channel is closed, and that these
residues are modiﬁed only in open channels. The measured rate of
modiﬁcation at these sites under different conditions would then
be determined both by the rate of modiﬁcation of open channels
and the open probability (which is varied under our different exper-
imental conditions). We have not measured the channel open prob-
ability under our experimental conditions, however, previous
results suggest that the modiﬁcation rates we measure are not in
fact linearly related to open probability. For example, reducing
ATP concentration to 10 μM is expected to decrease open probabili-
ty around tenfold [25], whereas the K464A mutation is usually
reported as having only a minor effect on open probability
[9,28,29]. Perhaps surprisingly, then, we ﬁnd the effects of low
ATP and the K464A mutation on modiﬁcation rate constants for
Q98C and I344C to be quantitatively similar and in the range of 1.5
to 3-fold (Figs. 3, 7).
Our present results also provide novel information on the effects of
Au(CN)2− on wild type CFTR. Cytoplasmic Au(CN)2− was originally de-
scribed as having dual inhibitory effects on CFTR, reducing both open
859W. Wang, P. Linsdell / Biochimica et Biophysica Acta 1818 (2012) 851–860probability (the “gating effect”) and Cl− ﬂux through open channels
(the “conductance effect”) [22]. While the gating effect appears to be
absent in cys-less CFTR (Fig. 4), the conductance effect seems unaltered
(Fig. 5). This suggests that the gating effect reﬂects a reduction in chan-
nel open probability that is caused by Au(CN)2−modiﬁcation of endog-
enous cysteine residues in the CFTR protein. The CFTR protein contains
18 cysteine residues, many of which are in important cytoplasmic do-
mains including NBD1, NBD2, the R domain and the C-terminal tail
[34]. Wild type CFTR is also potently inhibited by cytoplasmic MTS re-
agents [35], an effect which is not observed in cys-less [19], as well as
by the cysteine-reactive reagent p-chloromercuribenzosulfonate [36].
The endogenous site(s) of modiﬁcation that presumably underlie
these inhibitory effects are not known. Wild type CFTR is reversibly
inhibited by glutathionylation of C1344 in NBD2 [37]. In contrast to
the cysteine-mediated gating effect, the conductance effect is suggested
to reﬂect open channel block by Au(CN)2− ions [17,22] which is inde-
pendent of cysteine residues in the pore, consistent with earlier single
channel recordings of cys-less CFTR [20,32].
While K95C, Q98C and I344C were rapidly inhibited by low con-
centrations of cytoplasmic Au(CN)2− (Fig. 6), V345C showed similar
Au(CN)2− sensitivity as cys-less CFTR (data not shown). While the
reasons why V345C is apparently not modiﬁed by Au(CN)2− are
not clear, we have previously found that not all pore-lining cysteine
side chains that can be modiﬁed by MTS reagents can also be mod-
iﬁed by Au(CN)2− [14]. Furthermore, it has been shown that V345C
is insensitive to external Au(CN)2−, although cysteines substituted
for other nearby side chains are inhibited under similar conditions
[33].
5. Conclusions
Control of CFTR activity is by ATP interactions with the NBDs that
trigger a switch between “open” and “closed” conformations of the
TMDs. The structural basis of this conformational change is not current-
ly known. We propose that one functional consequence of ATP-
dependent channel opening is to allow access of cytoplasmic
substances beyond a “gate” located in the inner vestibule of the pore
and into the narrow pore region. Residues on the cytoplasmic side of
this gate (such as K95 in TM1 and V345 in TM6) are accessible to the
cytoplasm in both open and closed channels, whereas residues on the
external side of the gate (such as Q98 in TM1 and I344 in TM6) are like-
ly accessible only in open channels. The functional importance of this
gate is reﬂected in the ﬁnding that movement of permeant Au(CN)2−
ions—likely a good surrogate for Cl−—is regulated at this point in an
ATP concentration-dependent manner (Fig. 7). The nature of structural
change in the pore associated with opening of the gate is not known.
While different structural mechanisms may be used to open ion chan-
nels, we envision two different kinds of schemes, that emphasize global
(Fig. 8A) or localized (Fig. 8B) changes in pore structure during channel
opening. In the global model (Fig. 8A), structural rearrangement of the
TMDs lead to dilation and opening of a transmembrane pathway for
Cl− ions. The location of the “gate” then simply reﬂects the physical
limit beyondwhich cytoplasmic substances cannot pass in closed chan-
nels. Such a global rearrangement of the TMDs might be considered
consistent with the idea that ABC proteins switch between “inward fac-
ing” and “outward facing” TMD conformations during ATP-dependent
transport cycles [2,4–6]. In the localized model (Fig. 8B), the overall
structure of the permeation pathway is assumed not to change dramat-
ically during opening, but instead removal of a localized barrier at the
position of the channel gate allows access through this region. This
model has parallels in other ion channel types in which pore opening
is thought to be associated with the physical withdrawal of speciﬁc
amino acid side chains from the permeation pathway [38–41]. These
are simpliﬁed cartoonmodels and the actual structural rearrangements
underlying channel opening and closing may involve some aspects of
both global and local changes, as well as other kinds of structuralrearrangements such as rotational movements of individual TMs
[13,42]. The role of individual amino acid side chains, such as those lo-
cated close to the gate, in controlling channel opening and closing re-
main to be investigated.
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